Evidence map›Paper›PMID 35806100›Full record

ArticleInternational journal of molecular sciences2022

Thermal Shift Assay for Small GTPase Stability Screening: Evaluation and Suitability.

Kari Kopra, Salla Valtonen, Randa Mahran, Jonas N Kapp, Nazia Hassan, William Gillette, Bryce Dennis, Lianbo Li, Kenneth D Westover, Andreas Plückthun and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Fluorescence-Based Protein Stability Monitoring-A Review.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Luminescence-Based Techniques for KRAS Thermal Stability Monitoring.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  11. 1Current topics in medicinal chemistry · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Advances in Molecular Research of Oncogenes.International journal of molecular sciences · 2023
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Kari KopraDepartment of Chemistry, University of Turku, Henrikinkatu 2, 20500 Turku, Finland.ORCID 0000-0001-7585-6020
Salla ValtonenDepartment of Chemistry, University of Turku, Henrikinkatu 2, 20500 Turku, Finland.ORCID 0000-0002-4948-7169
Randa MahranDepartment of Chemistry, University of Turku, Henrikinkatu 2, 20500 Turku, Finland.
Jonas N KappDepartment of Biochemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.ORCID 0000-0002-7308-559X
Nazia HassanDepartment of Chemistry, University of Turku, Henrikinkatu 2, 20500 Turku, Finland.
William GilletteLeidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, 8560 Progress Dr., Frederick, MD 21702, USA.ORCID 0000-0002-8592-3642
Bryce DennisDepartments of Biochemistry and Radiation Oncology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, L4.270, Dallas, TX 75390, USA.
Lianbo LiDepartments of Biochemistry and Radiation Oncology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, L4.270, Dallas, TX 75390, USA.ORCID 0000-0003-0107-7125
Kenneth D WestoverDepartments of Biochemistry and Radiation Oncology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, L4.270, Dallas, TX 75390, USA.ORCID 0000-0003-3653-5923
Andreas PlückthunDepartment of Biochemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.ORCID 0000-0003-4191-5306
Harri HärmäDepartment of Chemistry, University of Turku, Henrikinkatu 2, 20500 Turku, Finland.
University of Turku · FIThe University of Texas Southwestern Medical Center · USUniversity of Zurich · CHLeidos (United States) · US

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MELANIE H. COBB · 2010 to 2026
$53.7M
Characterization and targeting of rapid nucleotide exchange RAS mutationsR01CA244341 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WESTOVER, KENNETH · 2020 to 2024
$1.8M
Academy of Finland 323433Academy of Finland 329012Emil Aaltonen FoundationNCI NIH HHS P30 CA142543NCI NIH HHS R01 CA244341Swiss Cancer Research foundation KFS-5290-02-2021Wellcome Trust 080867
6 · The paper itself

Abstract

Thermal unfolding methods are commonly used as a predictive technique by tracking the protein's physical properties. Inherent protein thermal stability and unfolding profiles of biotherapeutics can help to screen or study potential drugs and to find stabilizing or destabilizing conditions. Differential scanning calorimetry (DSC) is a 'Gold Standard' for thermal stability assays (TSA), but there are also a multitude of other methodologies, such as differential scanning fluorimetry (DSF). The use of an external probe increases the assay throughput, making it more suitable for screening studies, but the current methodologies suffer from relatively low sensitivity. While DSF is an effective tool for screening, interpretation and comparison of the results is often complicated. To overcome these challenges, we compared three thermal stability probes in small GTPase stability studies: SYPRO Orange, 8-anilino-1-naphthalenesulfonic acid (ANS), and the Protein-Probe. We studied mainly KRAS, as a proof of principle to obtain biochemical knowledge through TSA profiles. We showed that the Protein-Probe can work at lower concentration than the other dyes, and its sensitivity enables effective studies with non-covalent and covalent drugs at the nanomolar level. Using examples, we describe the parameters, which must be taken into account when characterizing the effect of drug candidates, of both small molecules and Designed Ankyrin Repeat Proteins.

Indexed as

Monomeric GTP-Binding ProteinsBiological AssayCalorimetry, Differential ScanningFluorometryProtein StabilityMonomeric GTP-Binding Proteinsdifferential scanning fluorimetry (DSF)GTPaseKRASProtein-ProbeSYPRO Orangethermal stability assay (TSA)

Identifiers

PMID35806100
PMCPMC9266822
OpenAlexW4283515101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.